Boston Marriott Cambridge
Cambridge, Massachusetts, United States
28 June - 4 July 2019
Conference 11070
17th International Photodynamic Association World Congress
Friday - Thursday 28 June - 4 July 2019 Conference Committee
Conference Sessions At A Glance
PDT School: Basic Sciences
Clinical Workshop: Neurosurgery
1: PDT in Food Safety and Solid Surface Sterilizations
2: PDT in Molecular and Personalized Medicine
3: Nanotechnology for Photodiagnosis
Poster Session
Thomas J. Dougherty Remembrance
4: PDT in the Brain
5: Nanotechnology for Photodynamic Therapy
6: Photosensitizing Systems
7: Capabilities of 5-ALA
8: PDT in Urology and Gynecology
9: Intracellular Mechanisms of PDT in Cancer
Posters-Sunday
Plenary Session 11070
Poster SLAM Talks
10: PDT for Thoracic Malignant Tumors
11: Photodynamic Immune Activation and Immunotherapy
12: Clinical and Immunological Aspects of PDT in Dermatology
13: Vascular Targeted PDT
14: PCI and Other Drug Delivery Methods
15: Photoactivated Chemotherapy: an Oxygen-Independent Form of Anticancer Phototherapy
16: Does PDT have a Role in Vaccine Development?
17: Global Funding Workshop
Tuesday Plenary Session
18: PDT in Head and Neck Cancer
19: Photoactivation in Drug Delivery
20: Applied and Mechanistic Issues of Anti-Microbial PDT
Wednesday Plenary Session
21: Macromolecular Targeted PDT: Is it Worth the Trouble or is it Too Early to Say?
22: Image-Guided Optimization and Prediction for Effective Photodynamic Therapy
23: Dosimetry and Interstitial PDT
24: PDT in Global Health: Global Access to Healthcare Challenges and Opportunities
25: Low-Cost Systems and Techniques in PDT Light Delivery, Dosimetry, and Treatment Guidance
26: Photodynamics and Ionizing Radiation: Friends or Foes?
27: Applications of Novel PDT Light Sources
28: From Small Animals to Spheroids: Modelling Mechanisms of PDT Effect on Tissue
29: Photodynamic Diagnosis and Therapy for Gastrointestinal Neoplastic Lesions
Roadmap to Impact: Challenges in Translating PDT Technologies and a Way Forward
Important Dates
Abstract Due:
25 January 2019

Author Notification:
22 March 2019

Manuscript Due Date:
5 July 2019

Friday 28 June Show All Abstracts
Coffee 9:30 AM - 10:00 AM
PDT School: Basic Sciences
Friday 28 June 2019
10:00 AM - 4:00 PM
Location: Salon 4

PDT School will provide a comprehensive review of the basic principles of PDT, as well as highlight the current state of PDT research and clinical application. Topics to be covered include photosensitizers and photochemistry, photophysics and dosimetry, antimicrobial PDT, biological aspects of PDT, and clinical translation of PDT.
Photosensitizers and photochemistry (Conference Presentation)
Paper 11070-701
Time: 10:00 AM - 11:00 AM
Author(s):
Show Abstract
Photophysics and dosimetry
Paper 11070-702
Time: 11:10 AM - 11:40 AM
Author(s):
Show Abstract
Lunch Break 11:40 AM - 1:00 PM
Antimicrobial PDT
Paper 11070-703
Time: 1:00 PM - 2:00 PM
Author(s):
Show Abstract
Photodynamic therapy: biological considerations
Paper 11070-704
Time: 2:10 PM - 3:10 PM
Author(s):
Show Abstract
Current clinical translation of PDT
Paper 11070-705
Time: 3:20 PM - 4:00 PM
Author(s):
Show Abstract
Saturday 29 June Show All Abstracts
Clinical Workshop: Neurosurgery
Saturday 29 June 2019
8:30 AM - 12:30 PM
Location: Salon 4

Intraoperative optical imaging now plays an important role in the surgical management of brain tumors for direct visualization of tumor tissue and more complete tumor resections. The most important recent event in surgical neuro-oncology has been the US FDA approval of 5-ALA (Gleolanâ) for fluorescence-guided surgery (FGS) of suspected high-grade gliomas. Visualization of the 5-ALA metabolite, protoporphyrin IX, permits delineation of the tumor during surgery to aid the neurosurgeon in real-time. As a complement to FGS, photodynamic therapy (PDT) has now become an important potential therapeutic approach for brain tumors. PDT is currently being studied at multiple sites globally both intra-operatively and for inoperable brain tumors. This workshop examines the past, present, and future of FGS and explores the origins and future potential applications of PDT.

11:50 pm - 12:30 pm Panel discussion (all presenters)
Fluorescence-guided neurosurgery and PDT: introduction
Paper 11070-706
Time: 8:30 AM - 8:50 AM
Author(s):
Show Abstract
Fluorescence-guided brain tumor neurosurgery
Paper 11070-707
Time: 8:50 AM - 9:10 AM
Author(s):
Show Abstract
Future of fluorescence-guided neurosurgery and PDT
Paper 11070-708
Time: 9:10 AM - 9:40 AM
Author(s):
Show Abstract
Fluorescence-guided surgery of meningiomas
Paper 11070-709
Time: 9:40 AM - 10:00 AM
Author(s):
Show Abstract
Coffee Break 10:00 AM - 10:30 AM
New applications of CNS tumor fluorescence-guided surgery
Paper 11070-710
Time: 10:30 AM - 10:50 AM
Author(s):
Show Abstract
Clinical practice of brain tumor photodynamic therapy
Paper 11070-711
Time: 10:50 AM - 11:10 AM
Author(s):
Show Abstract
Intraoperative photodynamic therapy of glioblastoma: the Japanese experience (Conference Presentation)
Paper 11070-712
Time: 11:10 AM - 11:30 AM
Author(s):
Show Abstract
Intraoperative photodynamic therapy of glioblastoma: the French experience
Paper 11070-713
Time: 11:30 AM - 11:50 AM
Author(s):
Show Abstract
Lunch Break 12:30 PM - 2:00 PM
Session 1: PDT in Food Safety and Solid Surface Sterilizations
Saturday 29 June 2019
2:00 PM - 3:45 PM
Location: Concept
Decolonization of pathogens on living surfaces by antimicrobial photodynamic action is possible? (Conference Presentation) (Invited Paper)
Paper 11070-1
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
Food safety: new challenge for PDT and photo reaction in general (Conference Presentation) (Invited Paper)
Paper 11070-2
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Chlorophyllin-based photosensitization for microbial control of fresh produce (Conference Presentation) (Invited Paper)
Paper 11070-3
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Antimicrobial photodynamic therapy mediated by chlorin e-6 photosensitizer against Streptococcus mutans biofilm (Conference Presentation)
Paper 11070-4
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Curcumin-based photosensitization: a novel and green technology to decontaminate food systems
Paper 11070-6
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
The potential of phytotherapeutic compounds available on the market as a new photosensitizers for dental antimicrobial PDT: a photochemical and photobiological in vitro study (Conference Presentation)
Paper 11070-7
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Coffee Break 3:45 PM - 4:30 PM
Session 2: PDT in Molecular and Personalized Medicine
Saturday 29 June 2019
2:00 PM - 4:05 PM
Location: Salons 5-7
Towards a personalized aminolevulinic acid (ALA)-based therapy (Conference Presentation) (Invited Paper)
Paper 11070-8
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
Phase I /II study of photodynamic therapy using talaporfin sodium and diode laser (L-PDT) for cervical intraepithelial neoplasia (Invited Paper)
Paper 11070-9
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Enhancement of immunotoxin effect on tumor with photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-10
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Management of multiple primary lung cancer in patients with centrally located early lung cancer lesions (Conference Presentation)
Paper 11070-11
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Porphyrin-lipid nanovesicles overcome ABC transporter-mediated multidrug resistance
Paper 11070-12
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Application of surgical curettage combined with photodynamic in refractory plantar wart
Paper 11070-14
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Salvage photodynamic therapy using new generation photosensitizer for local failure after chemoradiotherapy for esophageal cancer (Conference Presentation) (Invited Paper)
Paper 11070-416
Time: 3:45 PM - 4:05 PM
Author(s):
Show Abstract
Coffee Break 4:05 PM - 4:30 PM
Session 3: Nanotechnology for Photodiagnosis
Saturday 29 June 2019
2:00 PM - 4:00 PM
Location: Salon 4

This session is sponsored in part by:


Molecular afterglow imaging for cancer detection, drug screening, and imaging guided therapy (Invited Paper)
Paper 11070-85
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
From molecule to mammal: inventing luminescence nanoparticles for cancer therapy and visual enhancement (Invited Paper)
Paper 11070-86
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Advanced in vivo fluorescence imaging: seeing is believing (Invited Paper)
Paper 11070-87
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Biodegradable polymeric nanoparticles enhanced the effectiveness of topical PDT for squamous cell carcinoma
Paper 11070-88
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Dual function antibody conjugates (DFACs) for drug quantification and therapy (Conference Presentation)
Paper 11070-89
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Exploiting cellular delivery of conjugated polymer nanoparticles for improved photodynamic therapy in a 3D glioblastoma model
Paper 11070-90
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Targeting of epidermal growth factor receptor (EGFR)-positive pancreatic cancer cell lines with cetuximab-conjugated near-infrared silver sulphide quantum dots
Paper 11070-91
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Coffee Break 4:00 PM - 4:30 PM
Session PS1: Poster Session
Saturday 29 June 2019
4:30 PM - 6:30 PM
Location: Salons 1-3

Conference attendees are invited to attend the poster session on Saturday. Come view the posters, enjoy light refreshments, ask questions, and network with colleagues in your field. Authors of poster papers will be present to answer questions concerning their papers. Attendees are required to wear their conference registration badges to the poster sessions.

Poster Setup: Saturday 11:00 AM - 3:00 PM
Poster authors, view poster presentation guidelines and set-up instructions at http://spie.org/PDTPosterGuidelines.



Thank you to our Poster Session and Awards sponsors:


Superiority of diagnosis and treatment with multidisciplinary team in vascular anomalies
Paper 11070-307
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic priming and VDR activation modulate tumor-stroma interactions and permeability for durable control and enhanced treatment tolerability (Conference Presentation)
Paper 11070-193
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
DOSINDYGO: DOSe finding for INtraoperative photoDYnamic therapy of GliOblastoma
Paper 11070-194
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Verteporfin Photodynamic therapy with 5 aza-deoxy-cytidine for neo-adjuvant treatment of primary breast cancer: Results of pre-clinical investigations
Paper 11070-309
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Efficacy of photodynamic therapy using talaporfin sodium for glioblastoma stem cell
Paper 11070-195
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Analysis of the related factors of port-wine stains treated by Hematoporphyrin monomethyl ether photodynamic therapy
Paper 11070-311
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy activity of new porphyrin-xylan-coated silica nanoparticles in a human colorectal cancer in vivo model
Paper 11070-312
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Cancer stem cells and 5-aminolevulinic acid-PDT resistance
Paper 11070-197
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma
Paper 11070-198
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photosensitizer loaded photoacoustic nanodroplets for oxygen enhanced photodynamic therapy
Paper 11070-313
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Regulatory mechanism of acquired resistance against Talaporfin sodium-mediated photodynamic therapy-induced glioblastoma cell death
Paper 11070-199
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
In vitro study of membrane fusogenic liposomes as nanocarriers for non-melanoma skin cancer
Paper 11070-315
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Efficacy and safety of photodynamic therapy using talaporfin sodium and a semiconductor laser for patients with malignant meningeal tumors
Paper 11070-200
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Possible approaches to fluorescence diagnosis and photodynamic therapy for deep-seated tumors
Paper 11070-201
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
NIR light triggered photoimmuno-nanoconstructs for tumor specific accumulation, penetration and targeted destruction of pancreatic cancer cells in a clinically relevant 3D heterocellular model
Paper 11070-316
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Analysis of the effect of photodynamic therapy with Fotoenticine on gliosarcoma cells
Paper 11070-202
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Enhancement of biocompatibility and cancer-selectivity of iridium complex using cancer-environment-customized nanogel for minimally invasive photodynamic therapy
Paper 11070-317
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
ALA interstitial PDT (complicated and invasive) vs ALA sonodynamic therapy (SDT) (simple and noninvasive) for recurrent glioblastoma multiforme (RGBM): a comparison
Paper 11070-203
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Silica nanoparticles as photosensitizers carrier for photodynamic therapy
Paper 11070-318
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Determining an in vitro dose-response relationship of photodynamic therapy with first and second-generation photosensitisers for high grade tumours
Paper 11070-204
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A thin, flexible and transparent cranial window facilitates long-term and longitudinal studies on fluorescence imaging and photodynamic therapy
Paper 11070-205
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photochromic antifolate for light-activated chemotherapy
Paper 11070-320
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A novel theranostic tool for pediatric malignant tumor using ICG lactosome and near-infrared laser
Paper 11070-206
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A lead BODIPY-phenylanthracene dyad for application in photodynamic therapy
Paper 11070-321
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Singlet oxygen formation in photodynamic therapy using guaiazulene and red laser: an in vitro study
Paper 11070-322
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Handheld spectroscopic probe for ex-vivo analysis of quantitative 5-ALA fluorescence in diffusely infiltrating gliomas: correlation with histopathology, proliferation and microvascular density
Paper 11070-207
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Evaluation of a novel water soluble chlorin
Paper 11070-323
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Novel strategy to increase specificity of ALA-induced PpIX accumulation through inhibition of transporters involved in ALA uptake
Paper 11070-208
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Effects of irradiation modes in photodynamic therapy with azulene on singlet oxygen formation
Paper 11070-324
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Glioma tissue discrimination based on fluorescence lifetime imaging of protoporphyrin IX using a modulated time of flight camera
Paper 11070-209
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Influence of cationic, anionic or non-charged substituents on photodynamic activity of water-soluble zinc (aza)phthalocyanines
Paper 11070-325
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Effect of 5-aminolevulinic acid on the haem biosynthesis pathway in pancreatic cancer and pancreatic ductal epithelial cell lines
Paper 11070-210
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Superhydrophobic microtips: singlet oxygen delivery to biological sites without direct sensitizer contact
Paper 11070-326
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Protohypericin to hypericin photoconversion analysis by thermal lens spectrometry
Paper 11070-327
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Can low molecular weight stable bacteriochlorins change the paradigm of topical photodynamic therapy?
Paper 11070-329
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Comparison of the application of aminolevulinic acid and Fotoenticine in photodynamic therapy in gliosarcoma cell line
Paper 11070-213
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Enzyme-activatable photosensitizers for fluorescence-guided photodynamic therapy
Paper 11070-330
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Anti-wrinkle efficacy of chlorine e6 conjugates by photodynamic therapy
Paper 11070-332
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Investigation of protoporphyrin IX production induced by aminolevulinic acid combined with thermogenic and/or vasodilator substances
Paper 11070-216
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Experimental findings utilising a new iron chelating ALA prodrug to enhance protoporphyrin IX-induced photodynamic therapy
Paper 11070-217
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Targeted photo-therapy using a DDS-type near-infrared photo absorbing agent in colon cancer
Paper 11070-333
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Mechanism of tumor-specific porphyrin accumulation after administration of ALA
Paper 11070-218
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Temperature-controlled photothermal therapy for rat hepatocellular carcinoma using a near infrared absorbing agent
Paper 11070-335
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Iridium (III) complexes based photodynamic therapy
Paper 11070-336
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Evaluation of porphyrin metabolism in cancer cells for the therapeutic enhancement of aminolevulinic acid-mediated protoporphyrin IX
Paper 11070-219
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Intramolecular energy transfer based Iridium(III) photosensitizer for inducing mitochondrial oxidative stress and monitoring response
Paper 11070-337
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Application of 5-ALA in the resection of spinal ependymomas: a series of 30 cases
Paper 11070-220
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
In vitro validation of snap-tag based antibody fusion proteins conjugated to near infrared photosensitizers on melanoma
Paper 11070-338
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Clinical application of optical clearing agent combined with PDT for BCC treatment
Paper 11070-221
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A basic study of photodynamic therapy with glucose-conjugated chlorin e6 for canine mammary gland tumor
Paper 11070-339
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Detailed analysis of 5-ALA fluorescence in various brain metastases at two specialized centers: experience in 157 cases
Paper 11070-222
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Effect of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in treating condylomata acuminata in pregnancy
(Canceled)
Paper 11070-340
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Methylene blue as a photosensitizer in the photodynamic therapy of breast cancer cell lines
Paper 11070-341
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
ALA-PDT inducing pyroptosis of sebocytes via activation of NLRP3 inflammasome pathway
Paper 11070-224
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Enhancement of 5-aminolevulinic acid (5ALA) efficiency by conjugation to quantum dot nanoparticles
Paper 11070-225
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Rose bengal as a photosensitizer in the photodynamic therapy of breast cancer cell lines
Paper 11070-342
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Long-term effectiveness and HPV clearance of low and high-grade cervical lesions treated with photodynamic therapy
Paper 11070-226
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Superficial resection combined with photodynamic therapy for treatment of refractory vulval intraepithelial neoplasia
Paper 11070-227
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The influence of hypericin-mediated photodynamic therapy on secretion of selected interleukins by colon cancer cells in vitro
Paper 11070-345
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The influence of ALA-mediated photodynamic therapy on secretion of selected growth factors, interleukins and s100 protein (S100) by colon cancer cells in vitro
Paper 11070-346
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
5-ALA induces the distribution of endogenous PpIX fluorescence in cervical lesions
Paper 11070-230
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The effect of heme biosynthesis on the mitochondrial functions in C2C12 cels
Paper 11070-347
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The cytotoxicity of PDT is enhanced by hyperthermia enhance via regulation of HCP1 and ABCG2 expressions
Paper 11070-348
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A tumor mitochondria-targeted molecular agent for imaging-guided surgery and overcoming chemoresistance in ovarian cancer
Paper 11070-232
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Can glycolysis inhibitors potentiate photodynamic therapy?
Paper 11070-349
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Investigation of practical use of intraoperative laser marking of small pulmonary lesions
Paper 11070-233
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Near-infrared laser photothermal / photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress
Paper 11070-350
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Autofluorescence bronchoscopy findings for early-stage lung cancer in the central airway during photodynamic therapy
Paper 11070-234
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Undercover stromal cells: the effects of PDT
Paper 11070-352
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A new treatment for malignant pleural mesothelioma
Paper 11070-235
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Open-label phase IIb study to evaluation of safety, tolerability and efficacy of chlorin e6 (Fotolon) as a photosensitizer for the treatment of airway-obstructive non-small-cell lung cancer (NSCLC)
Paper 11070-236
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photobiomodulation inhibits Warburg metabolism and potentiates a dose dependent response by glioblastoma cells to ruthenium-based photodynamic therapy
Paper 11070-353
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Comparative study of VTP/radiation/cryoablation in a murine breast cancer model
Paper 11070-237
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Specific organelle damage by photosensitized oxidation are efficient modulators of proteasomal and autophagic degradation pathways
Paper 11070-354
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy as an effective adjuvant after surgical removal of prostate cancer
(Canceled)
Paper 11070-238
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Impact of photodynamic therapy on the regulation of human immune system in the context of hepatocellular carcinoma
(Canceled)
Paper 11070-239
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Overcoming drug resistance in pancreatic cancers
Paper 11070-357
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The role of proteoglycan genes in PDT-resistant HEp-2 cells
Paper 11070-358
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy with a novel zinc phthalocyanine: an innovative approach to hepatocellular carcinoma treatment
Paper 11070-359
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Annihilation of metastatic 4T1 breast tumor micrometastases by photodynamic therapy with gemcitabine
Paper 11070-241
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The interaction of thermal and photodynamic doses observed in interstitial PDT
Paper 11070-360
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Assessment of the analgesic effect of compound lidocaine cream in patients with port-wine stain treated by hemoporfin photodynamic therapy
Paper 11070-243
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Cadmium-free indium-based quantum dot nanoparticles as a novel contrast agent for biomedical applications
(Canceled)
Paper 11070-361
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Establishment of a system to measure talaporfin sodium concentrations in the skin after photodynamic therapy
Paper 11070-244
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Phototoxic effect of aluminum tetra-sulfonic phythalocyanine on chemo-resistant breast cancer cells
(Canceled)
Paper 11070-363
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Evaluation of effectiveness and long term follow up of a single visit PDT treatment for nodular basal cell carcinoma
Paper 11070-245
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Actinic keratosis: less pain during PDT treatment of large areas without decreasing efficacy
Paper 11070-246
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Evaluation of photodynamic therapy for precancerous lesions of female lower reproductive tract
Paper 11070-365
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The study of systematic nursing care to improve the treatment compliance of patients with condyloma who received photodynamic therapy
Paper 11070-247
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Superficial basal cell carcinoma treatment with a single visit PDT protocol
Paper 11070-248
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Application of surgery combined with photodynamic therapy in intractable skin tumors
Paper 11070-249
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodyamic therapy in combination with radio frequency electromagnetic field-mediated hyperthermia on cancer cells
Paper 11070-368
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Energy fluence rate impacts the efficacy of photodynamic therapy with methylene blue in breast cancer cells
(Canceled)
Paper 11070-369
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Application of photodynamic therapy in some refractory skin diseases
Paper 11070-252
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A severe inflammatory acne was successfully cleared by topical photodynamic therapy mediated with 5-aminolevulinic acid in an refractory aplastic anemia female patient: a case report
Paper 11070-256
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Topical hydrogen peroxide as a neoadjuvant treatment in the surgical excision of non-melanoma skin cancers
Paper 11070-375
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Evaluation of the efficacy of photodynamic therapy for the treatment of cutaneous horn: report of ten cases
Paper 11070-257
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Treatment of vulvar lichen sclerosus with combination of holmium laser and ALA-PDT: case report
Paper 11070-259
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The use of PBM to enhance tumor response in PDT
Paper 11070-378
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Hematoporphyrin mono-methylether photodynamic therapy (HMME-PDT) in treating port-wine stains (PWS) with Chinese patients
Paper 11070-260
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Near infrared photoimmunotherapy of GPA33-positive colorectal cancer in mice
(Canceled)
Paper 11070-380
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy for skin cancers: how to enhance 5-ALA penetration with dissolving microneedles?
Paper 11070-263
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Reactive oxygen species explicit dosimetry for Photofrin-mediated pleural photodynamic therapy
Paper 11070-381
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Autofluorescence endoscopic surveillance and photodynamic treatment of Barrett's esophagus
Paper 11070-382
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy of basal cell carcinoma with Levulon local application
Paper 11070-264
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The benefits of targeted endoscopic biopsy performed using the autofluorescence based diagnostic technique in gastrointestinal tumors
Paper 11070-383
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic therapy as a promising choice for pulsed dye laser-resistant port-wine stains: a retrospective study
Paper 11070-265
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Targeting oncogenic Ras/MEK pathway to improve visualisation of brain tumours using PpIX fluorescence
Paper 11070-385
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
How do modern sunscreens impact effective light dose in daylight photodynamic therapy?
Paper 11070-266
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Methylene blue-mediated photodynamic therapy on cutaneous leishmaniasis: an in vitro and in vivo study
Paper 11070-267
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Exploring metabolic heterogeneity and plasticity of peritoneal carcinomatosis to augment PDT as a theranostic treatment modality
Paper 11070-386
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Monitoring PDT response using a label-free multispectral lifetime fluorescence
Paper 11070-387
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
PDT in dermatology: quantification, relevance and comparison of light sources within a few clicks
Paper 11070-268
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Study of destruction effect of blood vessels after photodynamic therapy in a model of chorioallantoic membrane
Paper 11070-388
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Stimulation of apoptosis in systematically crossed cancer cell cultures by exudates from real tumors after PDT
Paper 11070-269
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A system for treatment and monitoring of skin lesion PDT in real time via fluorescence images of PpIX in NIR region
(Canceled)
Paper 11070-389
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Immunohistochemical analysis of Ki-67, EGFR, P-EGFR, CD31 and CD44 in early squamous cell carcinoma of the oral cavity treated with photodynamic therapy
Paper 11070-270
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Optical techniques for the microbiological control of blood
Paper 11070-271
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Optical techniques for decontamination of preservation fluids for transplantation of organ grafts
Paper 11070-272
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Real-time GPU accelerated hyperspectral unmixing (Conference Presentation)
Paper 11070-391
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Successful treatment of chromoblastomycosis using ALA-PDT in a patient with leukopenia
Paper 11070-273
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Micro-image mosaicking for video-rate multi-channel fluorescence microendoscopy
Paper 11070-392
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Viability of implementation in the field of photodynamic action to eliminate Aedes aegypti larvae
Paper 11070-274
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Fabrication of a fast fiber scanner for fluorescence microendoscopy (Conference Presentation)
Paper 11070-393
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Self-sterilizing photoactivated catheters to prevent nosocomial infections
Paper 11070-276
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Towards in-vivo molecular imaging as a tool for cancer cell phenotyping
Paper 11070-395
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Standard erythemal dose (SED) and UVA exposure during daylight photodynamic therapy (Conference Presentation)
Paper 11070-397
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic antimicrobial chemotherapy for treatment of peri-implantitis: a controlled, randomized, clinical trial
Paper 11070-278
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Stability evaluation of applicators for photodynamic therapy of oral cavity tumors with an endoscope
(Canceled)
Paper 11070-398
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Antimicrobial photodynamic therapy action over pathogens linked with healthcare-associated infections in patients with chronical periodontal disease
Paper 11070-279
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic inactivation applying at S. aureus biofilm developed at endotracheal tube
Paper 11070-280
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Design and evaluation of applicators for photodynamic therapy of oral cavity tumors in low resource settings (Conference Presentation)
Paper 11070-399
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Acidic pH might be the key for photodynamic elimination of biofilms
Paper 11070-281
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Determination of in-vivo tissue optical properties for anal photodynamic therapy
Paper 11070-400
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Electromagnetic tracking system for interstitial photodynamic therapy
Paper 11070-401
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Assessment of damages triggered by photodynamic therapy in Leishmania major and Leishmania braziliensis
Paper 11070-282
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A pilot study of antimicrobial photodynamic therapy of encapsulated Aspergillus fumigatus in a rabbit maxillary sinus model
Paper 11070-283
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A 2D singlet oxygen and photosensitizer imaging system for PDT
Paper 11070-402
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic inactivation of Candida albicans using a synthesized bacteriochlorin as a photosensitizer
Paper 11070-284
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Monte Carlo simulation for light delivery in turbid media improvement by a surface coupling agent
Paper 11070-403
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Antimicrobial PDT in South America
Paper 11070-285
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
ROS explicit dosimetry for ALA-mediated photodynamic therapy
Paper 11070-404
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Conquering carbapenem-resistant bacterial infections with photomedicine: from diagnosis to treatment
Paper 11070-286
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
A Monte Carlo investigation of the scatter light in cavity geometry
Paper 11070-405
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Fast and accurate simulations for PDT dosimetry
Paper 11070-406
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
New approaches for onychomycosis diagnosis and treatment by photodynamic therapy
Paper 11070-287
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Dual-wavelength (460 nm+405 nm) photo-inactivation of methicillin resistant Staphylococcus aureus
Paper 11070-288
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Elimination of methicillin resistant Staphylococcus aureus through photo-induced chemical bleaching of staphyloxanthin by antimicrobial blue light and pyocyanin
Paper 11070-289
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Laser coagulation test of cylindrical diffusing optical fiber probe for photo-dynamic therapy
Paper 11070-408
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Antimicrobial blue light inactivation of Moraxella catarrhalis
Paper 11070-290
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Low-cost fabrication of a custom LED array source for photodynamic therapy
(Canceled)
Paper 11070-411
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Sonophotodynamic Therapy for the inactivation of Staphylococcus aureus biofilm
Paper 11070-293
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
The therapeutic effectiveness of photodynamic therapy on vaginal intraepithelial neoplasia
Paper 11070-53
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Application of complex tissue engineering: variable control for clinical application of photothermal cancer therapy
Paper 11070-187
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies
Paper 11070-295
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Combining PDT with PD-1/PD-L1 blockade: can we find the key to enhanced antitumor response?
Paper 11070-412
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Tuning the photophysical properties of TiO2/porphyrin materials for visible light biomedical application
Paper 11070-413
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Targets of photodyamic inactivation in fungal cells
Paper 11070-414
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Antimicrobial effects of Photodynamic Therapy to gram negative bacteria envelope revealed by Cryo-electron tomography
Paper 11070-297
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Combinatorial antimicrobial therapy using a novel decacationic chlorin mediated antimicrobial photodynamic inactivation with covalently-bonded vancomycin against methicillin-resistant Staphylococcus aureus infections
Paper 11070-298
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Economic evaluation of photodynamic therapy implementation for non-melanoma skin cancer in the Brazilian public health system (Conference Presentation)
Paper 11070-300
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Nitromedicine
(Canceled)
Paper 11070-301
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photosensitizer contact time dependence on the necessary time for myocardial cell necrosis
Paper 11070-302
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activation
Paper 11070-303
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Photodynamic diagnosis uses chlrorin-e6 in the pancreatic cancer orthotopic models
Paper 11070-304
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Fluorescence colon tumor imaging by i.v. administered indocyanine green in a rat model of colon carcinogenesis
Paper 11070-306
Time: 4:30 PM - 6:30 PM
Author(s):
Show Abstract
Sunday 30 June Show All Abstracts
Thomas J. Dougherty Remembrance
Sunday 30 June 2019
8:30 AM - 10:30 AM
Location: Salon 4

The beginnings of PDT can be traced back to the work of Von Tapiener and Raab in 1900 and there were periodic re-discoveries over the years. Perhaps the most relevant of these was the work of Lipson and Schwartz who noted that the fluorescence of neoplasia could be traced to the presence of porphyrins and that artificially supplementing these porphyrins with something called HPD promoted this phenomenon. The field was mainly dormant until Thomas Dougherty began experimenting with photosensitization of neoplasia in the 1970s. It seems quite probable that clinical PDT and the advent of conferences such as this one would have never taken place but for Tom's efforts. In this session, a group that was involved in PDT, often from the early beginnings, will discuss the role Tom played in the development of the field and how important his persevering, in spite of numerous setbacks, was to the current status of PDT as a treatment option.
Thomas J. Dougherty: present at the creation
Paper 11070-714
Time: 8:30 AM - 8:45 AM
Author(s):
Show Abstract
Tom Dougherty, PDT, and myself (Conference Presentation)
Paper 11070-715
Time: 8:45 AM - 9:00 AM
Author(s):
Show Abstract
Much more than an impactful cancer scientist: Tom Dougherty as a graduate student advisor, mentor, advocate, and friend (Conference Presentation)
Paper 11070-716
Time: 9:00 AM - 9:15 AM
Author(s):
Show Abstract
Immunology and PDT: how a fantastic mentor encouraged expansion of PDT (Conference Presentation) (Invited Paper)
Paper 11070-717
Time: 9:15 AM - 9:30 AM
Author(s):
Show Abstract
From chemistry to clinical trials: remembering Dr. Thomas J. Dougherty as a pioneer of photodynamic therapy
Paper 11070-718
Time: 9:30 AM - 9:45 AM
Author(s):
Show Abstract
Clinical application: PDT with Tom Dougherty (Conference Presentation)
Paper 11070-719
Time: 9:45 AM - 10:00 AM
Author(s):
Show Abstract
Dr. Thomas J. Dougherty's remarkable vision for PDT drug
Paper 11070-720
Time: 10:00 AM - 10:15 AM
Author(s):
Show Abstract
Tom Dougherty and the FDA approval of PDT photosensitizers (Conference Presentation)
Paper 11070-721
Time: 10:15 AM - 10:30 AM
Author(s):
Show Abstract
Coffee Break 10:30 AM - 11:00 AM
Session 4: PDT in the Brain
Sunday 30 June 2019
11:00 AM - 1:00 PM
Location: Salons 5-7
Experience with 5-ALA PDD in different central nervous system tumors and future approaches (Invited Paper)
Paper 11070-23
Time: 11:00 AM - 11:20 AM
Author(s):
Show Abstract
The use of quantitative vs qualitative fluorescence for neurosurgical guidance and resection of brain tumors (Invited Paper)
Paper 11070-24
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
Photodynamic therapy of brain tumor stem cells overcomes drug-resistance in preclinical models (Conference Presentation) (Invited Paper)
Paper 11070-22
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Efficacy of ruthenium coordination complex based Rutherrin in a pre-clinical rat glioblastoma (GBM) model (Conference Presentation)
Paper 11070-26
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
INDYGO: intraoperative PDT for newly diagnosed GBM, 2-years follow-up (Conference Presentation)
Paper 11070-180
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Comparative analysis of 5-ALA-induced fluorescence intensity and 11C-Methionine PET uptake in glioma surgery
Paper 11070-27
Time: 12:30 PM - 12:45 PM
Author(s):
Show Abstract
Photodynamic opening of blood-brain barrier as a new method for brain drug delivery
(Canceled)
Paper 11070-28
Time: 12:45 PM - 1:00 PM
Author(s):
Show Abstract
Lunch Break 1:00 PM - 2:30 PM
Session 5: Nanotechnology for Photodynamic Therapy
Sunday 30 June 2019
11:00 AM - 1:00 PM
Location: Salon 4

This session is sponsored by:


Photodynamic nanomedicine synchronizes cytotoxic and molecular therapies to suppress multiple treatment escape pathways (Conference Presentation) (Invited Paper)
Paper 11070-31
Time: 11:00 AM - 11:20 AM
Author(s):
Show Abstract
Reactive oxygen species goes beyond photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-30
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
Porphyrin nanomedicine: from fundamentals to applications (Invited Paper)
Paper 11070-29
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Photosensitizing biomolecules and nanocrystals for anti-glioma photodynamic therapy (Conference Presentation)
Paper 11070-32
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Therapeutic response of experimental choroidal neovascularization in mice with photodynamic/photothermal therapy using ICG loaded gold nanorods as a photosensitizer
Paper 11070-33
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Antimicrobial photodynamic inactivation by cationic (TMPyP4) and anionic (TPPS4) porphyrins and effect of potassium iodide
(Canceled)
Paper 11070-34
Time: 12:30 PM - 12:45 PM
Author(s):
Show Abstract
Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting
Paper 11070-35
Time: 12:45 PM - 1:00 PM
Author(s):
Show Abstract
Lunch Break 1:00 PM - 2:30 PM
Session 6: Photosensitizing Systems
Sunday 30 June 2019
11:00 AM - 12:55 PM
Location: Concept
How potent should a photosensitizer be? (Conference Presentation) (Invited Paper)
Paper 11070-36
Time: 11:00 AM - 11:20 AM
Author(s):
Show Abstract
Design and development of metal complex photosensitizers for photodynamic therapy (Invited Paper)
Paper 11070-38
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
TSPO-targeted agents for PDT of aggressive tumors (Withdrawal Notice)
Paper 11070-39
Time: 11:40 AM - 11:55 AM
Author(s):
Show Abstract
Alternative photosensitizers based on BODIPY chromophore (Conference Presentation)
Paper 11070-40
Time: 11:55 AM - 12:10 PM
Author(s):
Show Abstract
Novel metal-based photosensitizers for photodynamic therapy: exploratory study (Conference Presentation)
Paper 11070-41
Time: 12:10 PM - 12:25 PM
Author(s):
Show Abstract
Investigation of nano immunotherapy drug delivery in lung cancer cells
Paper 11070-42
Time: 12:25 PM - 12:40 PM
Author(s):
Show Abstract
Singlet oxygen traps: from synthesis to phototherapy
Paper 11070-420
Time: 12:40 PM - 12:55 PM
Author(s):
Show Abstract
Lunch Break 12:40 PM - 2:30 PM
Session 7: Capabilities of 5-ALA
Sunday 30 June 2019
2:30 PM - 4:30 PM
Location: Salons 5-7

This session is sponsored in part by:


Enhanced visualisation of glioma using 5-ALA (Invited Paper)
Paper 11070-43
Time: 2:30 PM - 2:50 PM
Author(s):
Show Abstract
Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a Phase II randomized controlled trial (Conference Presentation) (Invited Paper)
Paper 11070-44
Time: 2:50 PM - 3:10 PM
Author(s):
Show Abstract
Interstitial photodynamic therapy (iPDT) of brain tumours (Conference Presentation) (Invited Paper)
Paper 11070-45
Time: 3:10 PM - 3:30 PM
Author(s):
Show Abstract
Current clinical studies on 5-ALA-FD (5-aminolevulinic acid mediated-fluorescence guided detection) in detection of lung, gastric, pancreatic, and bladder cancers in Japan (Conference Presentation)
Paper 11070-46
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Evaluation of dissolving microneedles with aminolevulinic acid in human skin - a pilot study
Paper 11070-47
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Photodynamic therapy as an alternative to antibiotic therapy for the treatment of infected leg ulcers (Conference Presentation)
Paper 11070-48
Time: 4:00 PM - 4:15 PM
Author(s):
Show Abstract
5-Aminolevulinic acid photodynamic therapy: an effective treatment modality for female precancerous lesions: experience of a single center
Paper 11070-49
Time: 4:15 PM - 4:30 PM
Author(s):
Show Abstract
Coffee Break 4:30 PM - 5:00 PM
Session 8: PDT in Urology and Gynecology
Sunday 30 June 2019
2:30 PM - 4:30 PM
Location: Concept
Phosphorescent photosensitizers as potential drugs in new theranostic flim/plim procedures (Invited Paper)
Paper 11070-50
Time: 2:30 PM - 2:50 PM
Author(s):
Show Abstract
TLD-1433 photodynamic therapy for BCG-unresponsive NMIBC: a Phase IB clinical study (Conference Presentation) (Invited Paper)
Paper 11070-51
Time: 2:50 PM - 3:10 PM
Author(s):
Show Abstract
Treatment of peritoneal carcinomatosis of various origins by photodynamic therapy: state of the art (Conference Presentation) (Invited Paper)
Paper 11070-52
Time: 3:10 PM - 3:30 PM
Author(s):
Show Abstract
Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of cervical low grade squamous intraepithelial lesion
Paper 11070-344
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Intraperitoneal photodynamic therapy for ovarian cancer: a novel way to stimulate anti-tumoral immune response?
Paper 11070-54
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Preliminaries results of clinical study of condylomas acuminate using PDT with new illumination devices (Conference Presentation)
Paper 11070-55
Time: 4:00 PM - 4:15 PM
Author(s):
Show Abstract
Coffee Break 4:30 PM - 5:00 PM
Session 9: Intracellular Mechanisms of PDT in Cancer
Sunday 30 June 2019
2:30 PM - 4:30 PM
Location: Salon 4
The role of death pathways in the efficacy of photokilling (Invited Paper)
Paper 11070-57
Time: 2:30 PM - 2:50 PM
Author(s):
Show Abstract
Mechanisms of PDT-induced Immunogenic cell death: implications for photochemical internalization (Invited Paper)
Paper 11070-58
Time: 2:50 PM - 3:10 PM
Author(s):
Show Abstract
Targeted PDT-based combinations for cancer: sub-cellular sites and cytotoxic mechanisms (Conference Presentation) (Invited Paper)
Paper 11070-59
Time: 3:10 PM - 3:30 PM
Author(s):
Show Abstract
Capecitabine (Xeloda) enhanced photodynamic therapy for treatment of breast cancer and its metastases in a murine breast tumor model (Conference Presentation)
Paper 11070-60
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Mitochondria targeted BODIPY-based photosensitizers for treatment of hypoxic tumors
Paper 11070-61
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Redaporfin targets the endoplasmatic reticulum and the golgi apparatus and is an inducer of immunogenic cell death
Paper 11070-62
Time: 4:00 PM - 4:15 PM
Author(s):
Show Abstract
Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy
Paper 11070-63
Time: 4:15 PM - 4:30 PM
Author(s):
Show Abstract
Coffee Break 4:30 PM - 5:00 PM
Session PS2: Posters-Sunday
Sunday 30 June 2019
4:30 PM - 6:30 PM
Location: Salons 1-3

Conference attendees are invited to attend the poster session on Sunday. Come view the posters, enjoy light refreshments, ask questions, and network with colleagues in your field. Authors of poster papers will be present to answer questions concerning their papers. Attendees are required to wear their conference registration badges to the poster sessions.

Poster Setup: Sunday 11:00 AM - 3:00 PM
Poster authors, view poster presentation guidelines and set-up instructions at http://spie.org/PDTPosterGuidelines.



Thank you to our Poster Session and Awards sponsors:


Monday 1 July Show All Abstracts
Session PL1: Plenary Session 11070
Monday 1 July 2019
8:30 AM - 10:00 AM
Location: Salon 4
Macromolecular targeting of cancer: challenges in science and translation (Plenary Presentation)
Paper 11070-505
Time: 9:00 AM - 10:00 AM
Author(s):
Show Abstract
Photochemistry and the origin of life (Conference Presentation) (Plenary Presentation)
Paper 11070-503
Time: 9:00 AM - 10:00 AM
Author(s):
Show Abstract
Re-engineering the tumor microenvironment to enhance cancer treatment: bench to bedside (Plenary Presentation)
Paper 11070-501
Time: 8:30 AM - 9:15 AM
Author(s):
Show Abstract
Next-generation immune checkpoints: deciphering key roles in the TME (Plenary Presentation)
Paper 11070-502
Time: 9:15 AM - 10:00 AM
Author(s):
Show Abstract
Antimicrobial PDT: progress and challenges at the IPA 2019 meeting? (Plenary Presentation)
Paper 11070-504
Time: 10:00 AM - 10:30 AM
Author(s):
Show Abstract
Coffee Break 10:00 AM - 10:30 AM
Poster SLAM Talks
Monday 1 July 2019
10:30 AM - 12:30 PM
Location: Concept

Among the poster participants from the two Poster Sessions, 10 participants will be selected and will be given an opportunity to present their posters as oral presentation (1 slide, 3 minutes). In the 3 minutes, they will explain their research poster to the jury. Winners will be selected from the SLAM talk presentations. The top four winners will be awarded the Poster of Prestige and the next six will be awarded the Poster of Excellence. Nominal amount of cash will be part of the awards.
Lunch Break & General Assembly 12:30 PM - 2:00 PM
Session 10: PDT for Thoracic Malignant Tumors
Monday 1 July 2019
10:30 AM - 12:30 PM
Location: Salons 5-7
Optical coherence tomography for the detection, diagnosis, and monitoring of pulmonary disease and thoracic malignancies (Conference Presentation) (Invited Paper)
Paper 11070-64
Time: 10:30 AM - 10:50 AM
Author(s):
Show Abstract
Photodynamic therapy for peripheral-type lung cancer in a multi-center clinical trial (Invited Paper)
Paper 11070-65
Time: 10:50 AM - 11:10 AM
Author(s):
Show Abstract
Combining immunooncology agents and PDT in thoracic oncology: once more back to the bench, dear friends (Conference Presentation) (Invited Paper)
Paper 11070-66
Time: 11:10 AM - 11:30 AM
Author(s):
Show Abstract
Fluorodynamic diagnosis of thoracic malignancies
Paper 11070-67
Time: 11:30 AM - 11:45 AM
Author(s):
Show Abstract
Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients
Paper 11070-68
Time: 11:45 AM - 12:00 PM
Author(s):
Show Abstract
Combination therapy with photodynamic therapy in lung cancer (Conference Presentation)
Paper 11070-69
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
A novel photodynamic therapy technique for peripheral lung tumor (Conference Presentation)
Paper 11070-70
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Lunch Break & General Assembly 12:30 PM - 2:00 PM
Session 11: Photodynamic Immune Activation and Immunotherapy
Monday 1 July 2019
10:30 AM - 12:30 PM
Location: Salon 4
Photochemical internalization (PCI) of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity (Conference Presentation) (Invited Paper)
Paper 11070-71
Time: 10:30 AM - 10:50 AM
Author(s):
Show Abstract
Augmentation of PDT-enhanced anti-tumor immunity and implications for immune checkpoint blockade (Invited Paper)
Paper 11070-72
Time: 10:50 AM - 11:10 AM
Author(s):
Show Abstract
Nanoscale metal-organic framework-mediated photodynamic therapy enhances checkpoint blockade immunotherapy (Invited Paper)
Paper 11070-73
Time: 11:10 AM - 11:30 AM
Author(s):
Show Abstract
Photo triggered liposomes for delivery of immunostimulatory cytokines to solid tumors
Paper 11070-74
Time: 11:30 AM - 11:45 AM
Author(s):
Show Abstract
Epidermal growth factor receptor: targeted photoimmunotherapy is fluence rate dependent in-vivo (Conference Presentation)
Paper 11070-75
Time: 11:45 AM - 12:00 PM
Author(s):
Show Abstract
Analysis of cell death and immune response in metronomic versus conventional photodynamic therapy of actinic keratosis in a murine model (Conference Presentation)
Paper 11070-76
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Development of anti-cadherin-17 antibody -IR700 conjugate for photodynamic therapy against gastrointestinal cancers
Paper 11070-77
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Lunch Break & General Assembly 12:30 PM - 2:00 PM
Session 12: Clinical and Immunological Aspects of PDT in Dermatology
Monday 1 July 2019
2:00 PM - 4:00 PM
Location: Salons 5-7
Personalized combination regimens improve PDT outcomes for actinic keratoses and skin cancer (Invited Paper)
Paper 11070-78
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
Immune effects of ALA-PDT for cutaneous squamous cell carcinoma (Invited Paper)
Paper 11070-79
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Insights gained from regression analysis of PpIX fluorescence imaging undertaken during routine dermatological photodynamic therapy (Invited Paper)
Paper 11070-80
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Photodynamic therapy for squamous cell carcinoma in situ
Paper 11070-81
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Photodynamic therapy for actinic keratosis: a trend towards a decrease in irradiance without loss of efficacy for a better tolerability
Paper 11070-82
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Non-invasive skin evaluation for assessing treatment efficacy of port-wine stains (Conference Presentation)
Paper 11070-83
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Skin photoaging improved by ALA-PDT: from clinical to mechanism study
Paper 11070-84
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Coffee Break 4:00 PM - 4:30 PM
Session 13: Vascular Targeted PDT
Monday 1 July 2019
2:00 PM - 4:00 PM
Location: Salon 4

This session is sponsored in part by:
Clinical trial experience with Tookad soluble vascular targeted photodynamic therapy for genitourinary cancers at Memorial Sloan Ketterin (Conference Presentation) (Invited Paper)
Paper 11070-15
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
WST11-VTP (Tookad soluble)is safe in the luminal treatment of obstructing esophago-gastric cancer (Conference Presentation) (Invited Paper)
Paper 11070-16
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Vascular targeted photodynamic therapy with Tookad: from local ablation to systemic cancer treatment (Conference Presentation) (Invited Paper)
Paper 11070-17
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Combinatorial approaches with vascular photodynamic therapy with redaporfin and immune checkpoint blockers (Conference Presentation)
Paper 11070-18
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Safety and efficacy of photosensitizer Photolon (Fotolon) in photodynamic therapy
Paper 11070-19
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Vandetanib sensitises oral squamous cell carcinoma to photodynamic therapy through NHEJ impairment and modulation of tumour microenvironment (Conference Presentation)
Paper 11070-20
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Complexation of WST11 (Tookad soluble) by serum albumin modulates the photosensitizer's ability to generate free radicals and singlet oxygen
Paper 11070-21
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Coffee Break 4:00 PM - 4:30 PM
Session 14: PCI and Other Drug Delivery Methods
Monday 1 July 2019
2:00 PM - 3:45 PM
Location: Concept

This session is sponsored in part by:
The scientific basis of photochemical internalization (PCI) (Conference Presentation) (Invited Paper)
Paper 11070-92
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
Review of photochemical internalisation (PCI) applications (Conference Presentation) (Invited Paper)
Paper 11070-93
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Photochemical internalization: current clinical trials in cholangiocarcinoma (Conference Presentation) (Invited Paper)
Paper 11070-94
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Initial clinical studies with PCI (Conference Presentation)
Paper 11070-95
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Light-induced permeabilization of liposomes
Paper 11070-96
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Enhancing the efficacy of drug released from loaded fibrin glue by photochemical internalization (PCI)
Paper 11070-97
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Coffee Break 3:45 PM - 4:30 PM
Session 15: Photoactivated Chemotherapy: an Oxygen-Independent Form of Anticancer Phototherapy
Monday 1 July 2019
4:30 PM - 6:15 PM
Location: Salons 5-7
Dual action photoactive transition metal complexes for photochemotherapy (Invited Paper)
Paper 11070-98
Time: 4:30 PM - 4:50 PM
Author(s):
Show Abstract
Red-light-responsive Ru-containing polymers for deep-tissue biomedical applications (Conference Presentation) (Invited Paper)
Paper 11070-99
Time: 4:50 PM - 5:10 PM
Author(s):
Show Abstract
Photoactivated chemotherapy in hypoxic cancer cells (Conference Presentation) (Invited Paper)
Paper 11070-100
Time: 5:10 PM - 5:30 PM
Author(s):
Show Abstract
Light emitting fabrics for photodynamic treatment of vulvar primary extramammary Paget's disease
Paper 11070-101
Time: 5:30 PM - 5:45 PM
Author(s):
Show Abstract
Near infrared light-mediated delivery of anticancer agents (Conference Presentation)
Paper 11070-102
Time: 5:45 PM - 6:00 PM
Author(s):
Show Abstract
Novel mechanism of dendritic cell maturation by dying/death tumor cells via photodynamic modulation of type 1 interferon pathway
Paper 11070-103
Time: 6:00 PM - 6:15 PM
Author(s):
Show Abstract
Session 16: Does PDT have a Role in Vaccine Development?
Monday 1 July 2019
4:30 PM - 6:30 PM
Location: Salon 4
Specific immuno-photodynamic therapy of cancer (Invited Paper)
Paper 11070-105
Time: 4:30 PM - 4:50 PM
Author(s):
Show Abstract
Cancer PDT vaccines: progress and prospects (Conference Presentation) (Invited Paper)
Paper 11070-106
Time: 4:50 PM - 5:10 PM
Author(s):
Show Abstract
Measuring and modulating tumor microenvironment in PDT: an immunological perspective (Invited Paper)
Paper 11070-107
Time: 5:10 PM - 5:30 PM
Author(s):
Show Abstract
Phase I clinical study for validation of photochemical internalisation (fimaVacc): a novel technology for enhancing cellular immune responses important for therapeutic effect of peptide- and protein-based vaccines (Conference Presentation) (Invited Paper)
Paper 11070-108
Time: 5:30 PM - 5:45 PM
Author(s):
Show Abstract
Understanding the first steps towards immune-modulation triggered by nanobody-targeted photodynamic therapy (Conference Presentation)
Paper 11070-109
Time: 5:45 PM - 6:00 PM
Author(s):
Show Abstract
A new platform technology RuVaCare, an extracorporeal anti-cancer vaccine is efficient in breaking immune barrier to target cancer cells (Conference Presentation)
Paper 11070-110
Time: 6:00 PM - 6:15 PM
Author(s):
Show Abstract
Photodynamic therapy induced prostaglandin E2 plays an unexpected beneficial role in the generation of anti-tumor immunity
Paper 11070-111
Time: 6:15 PM - 6:30 PM
Author(s):
Show Abstract
Session 17: Global Funding Workshop
Monday 1 July 2019
4:30 PM - 6:30 PM
Location: Concept

The IPA Global Funding Workshop brings together a series of fundamental, translational and clinical researchers at different stages of their careers whose research in photodynamic therapy has been funded by organizations and institutions from across the globe. The purpose of this two-part workshop is to provide global insights, and personal experiences of obtaining funding strategies for research in photodynamic therapy. These include career transition awards, junior investigator awards, clinical-basic research partnerships. The workshop will also include a "Mentor’s Word of Advice" from Dr. Tayyaba Hasan. Join us at the IPA Global Funding Workshop to learn about career trajectories and how to fund your research from experienced and well-funded investigators from North America, Europe and Japan.
Tuesday 2 July Show All Abstracts
Session PL2: Tuesday Plenary Session
Tuesday 2 July 2019
9:00 AM - 10:30 AM
Location: Salon 4
Coffee Break 10:30 AM - 11:00 AM
Session 18: PDT in Head and Neck Cancer
Tuesday 2 July 2019
11:00 AM - 1:00 PM
Location: Salon 3
Developing world applications of PDT in head and neck cancer (Conference Presentation) (Invited Paper)
Paper 11070-113
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
EGFR-targeted fluorescence guided surgery in head and neck cancer (Conference Presentation) (Invited Paper)
Paper 11070-114
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Surgical navigation in oral tongue cancer resections (Conference Presentation)
Paper 11070-115
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Interstitial PDT treatment planning and dosimetry for locally advanced head and neck squamous cell carcinoma
Paper 11070-116
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Interpretation of ultrasonography indicators of photodynamic therapy treatment response in early malignancy of buccal mucosa (Conference Presentation)
Paper 11070-117
Time: 12:30 PM - 12:45 PM
Author(s):
Show Abstract
Investigation of the implications of atropisomersim for redaporfin-photodynamic therapy efficacy (Conference Presentation)
Paper 11070-118
Time: 12:45 PM - 1:00 PM
Author(s):
Show Abstract
Lunch Break 1:00 PM - 2:30 PM
Session 19: Photoactivation in Drug Delivery
Tuesday 2 July 2019
11:00 AM - 1:00 PM
Location: Salon 4
Control of local tumors by light-activatable prodrugs for PDT and site-specific chemotherapy: PB/PKPD-based optimization of the treatment conditions (Invited Paper)
Paper 11070-119
Time: 11:00 AM - 11:20 AM
Author(s):
Show Abstract
Surface modified nanoparticles mediate selective photodynamic therapy against tumor stroma (Invited Paper)
Paper 11070-120
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
Multifunctional polysilsesquioxane nanoparticle-based platform for the treatment of triple-negative breast cancer in vitro and in vivo using chemo and photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-121
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Single-agent liposomal chemophototherapy for rat mammary tumors (Conference Presentation)
Paper 11070-122
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Photo-immunoconjugated liposomal irinotecan for triple combination cancer therapy
Paper 11070-123
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Combination light-based therapies to treat pancreatic cancer: a proof of concept
Paper 11070-124
Time: 12:30 PM - 12:45 PM
Author(s):
Show Abstract
Mild hyperthermia enhances drug accumulation and photodynamic therapy efficacy
Paper 11070-125
Time: 12:45 PM - 1:00 PM
Author(s):
Show Abstract
Lunch Break 1:00 PM - 2:30 PM
Session 20: Applied and Mechanistic Issues of Anti-Microbial PDT
Tuesday 2 July 2019
11:00 AM - 1:00 PM
Location: Salons 1-2
Mutants of E. coli, which lack antioxidant enzymes, are more susceptible towards type-1 mechanism of action of photoantimicrobials compared to type-2 photoantimicrobials (Conference Presentation) (Invited Paper)
Paper 11070-126
Time: 11:00 AM - 11:20 AM
Author(s):
Show Abstract
Antimicrobial photodynamic therapy: from basis to clinical applications (Invited Paper)
Paper 11070-127
Time: 11:20 AM - 11:40 AM
Author(s):
Show Abstract
Butyl toluidine blue: an improved phenothiazinium photoantimicrobial (Invited Paper)
(Canceled)
Paper 11070-128
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Antibiotic resistance: is there a (blue) light at the end of the tunnel? (Invited Paper)
Paper 11070-419
Time: 11:40 AM - 12:00 PM
Author(s):
Show Abstract
Photodynamic inactivation of bacterial pneumonia with extracorporeal illumination: current developments
Paper 11070-129
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Advances in the clinical application of photodynamic action for pharyngotonsillitis treatment (Conference Presentation)
Paper 11070-130
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
The mechanisms of bacterial inactivation via MB-APDT avoid drug resistance (Conference Presentation)
Paper 11070-131
Time: 12:30 PM - 12:45 PM
Author(s):
Show Abstract
Correlation between 405-nm antimicrobial blue light inactivation of multidrug-resistant microorganisms and the endogenous porphyrin content
Paper 11070-132
Time: 12:45 PM - 1:00 PM
Author(s):
Show Abstract
Lunch Break 1:00 PM - 2:30 PM
Wednesday 3 July Show All Abstracts
Session PL3: Wednesday Plenary Session
Wednesday 3 July 2019
9:00 AM - 10:00 AM
Location: Salon 4
Coffee Break 10:00 AM - 10:30 AM
Session 21: Macromolecular Targeted PDT: Is it Worth the Trouble or is it Too Early to Say?
Wednesday 3 July 2019
10:30 AM - 12:30 PM
Location: Salon 3
Seeing is believing: integrating therapy with imaging in preclinical cancer models (Invited Paper)
Paper 11070-417
Time: 10:35 AM - 10:55 AM
Author(s):
Show Abstract
EGFR-targeted photosensitizer-peptide conjugates (Conference Presentation) (Invited Paper)
Paper 11070-135
Time: 10:55 AM - 11:15 AM
Author(s):
Show Abstract
Nanobody-targeted photodynamic therapy selectively kills viral GPCR-expressing glioblastoma cells
Paper 11070-138
Time: 11:15 AM - 11:30 AM
Author(s):
Show Abstract
Selectivity versus specificity in the world of molecular targeted photonanomedicines: a nanoscale conundrum
Paper 11070-418
Time: 11:30 AM - 11:45 AM
Author(s):
Show Abstract
Radionuclide stimulated therapy
Paper 11070-136
Time: 11:45 AM - 12:00 PM
Author(s):
Show Abstract
Long-circulating prostate-specific membrane antigen-targeted NIR phototheranostic agent
Paper 11070-137
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6 (Conference Presentation)
Paper 11070-139
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Lunch Break 12:30 PM - 2:00 PM
Session 22: Image-Guided Optimization and Prediction for Effective Photodynamic Therapy
Wednesday 3 July 2019
10:30 AM - 12:30 PM
Location: Salon 4
Fluorescence-guided surgery and margin analysis with panitumumab-IRDye800: initial experience in head and neck cancer (Invited Paper)
Paper 11070-140
Time: 10:30 AM - 10:50 AM
Author(s):
Show Abstract
Optical imaging guided photodynamic therapy monitoring and optimization (Conference Presentation) (Invited Paper)
Paper 11070-141
Time: 10:50 AM - 11:10 AM
Author(s):
Show Abstract
Possibilities of utilizing multi-parametric Imaging to predict photodynamic therapy response in tumor models (Invited Paper)
Paper 11070-142
Time: 11:10 AM - 11:30 AM
Author(s):
Show Abstract
Molecularly targeted imaging in multiple myeloma (Conference Presentation)
Paper 11070-143
Time: 11:30 AM - 11:45 AM
Author(s):
Show Abstract
The role of medical imaging in the context of photodynamic therapy
Paper 11070-144
Time: 11:45 AM - 12:00 PM
Author(s):
Show Abstract
5-aminolevulinic acid as a potential contrast agent for image-guided surgery in pancreatic cancer
Paper 11070-145
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Dosimetry recommendations for NMIBC: a simulation and in vivo study (Conference Presentation)
Paper 11070-146
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Lunch Break 12:30 PM - 2:00 PM
Session 23: Dosimetry and Interstitial PDT
Wednesday 3 July 2019
10:30 AM - 12:30 PM
Location: Salons 1-2
Dose planning and real-time dosimetry in interstitial PDT of recurrent prostate cancer (Invited Paper)
Paper 11070-147
Time: 10:30 AM - 10:50 AM
Author(s):
Show Abstract
Pretreatment planning and light dosimetry for interstitial PDT of locally advanced cancer (Conference Presentation) (Invited Paper)
Paper 11070-148
Time: 10:50 AM - 11:10 AM
Author(s):
Show Abstract
Dosimetric considerations for intra cavity photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-149
Time: 11:10 AM - 11:30 AM
Author(s):
Show Abstract
Modelling novel PDT approaches to target peripheral lung cancers (Conference Presentation)
Paper 11070-150
Time: 11:30 AM - 11:45 AM
Author(s):
Show Abstract
Computational evaluation of the effect of interstitial PDT with 5-ALA for pretreatment planning (Conference Presentation)
Paper 11070-151
Time: 11:45 AM - 12:00 PM
Author(s):
Show Abstract
Light dosimetry and monitoring approaches for interstitial photodynamic therapy (iPDT)
Paper 11070-152
Time: 12:00 PM - 12:15 PM
Author(s):
Show Abstract
Computational guided dosimetry for the safe and effective treatment of locally advanced VX2 carcinoma with interstitial photodynamic therapy (Conference Presentation)
Paper 11070-153
Time: 12:15 PM - 12:30 PM
Author(s):
Show Abstract
Lunch Break 12:30 PM - 2:00 PM
Session 24: PDT in Global Health: Global Access to Healthcare Challenges and Opportunities
Wednesday 3 July 2019
2:00 PM - 3:45 PM
Location: Salon 3
Global opportunities for PDT (Conference Presentation) (Invited Paper)
Paper 11070-154
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
Oncological PDT in Latin America (Conference Presentation) (Invited Paper)
Paper 11070-155
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
The role of PDT in nasopharyngeal cancer in Indonesia (Conference Presentation) (Invited Paper)
Paper 11070-156
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Photodynamic therapy as an alternative treatment modality for early stage buccal mucosa malignancy (Conference Presentation)
Paper 11070-157
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
How important are the contact-dependent reactions to the outcome of PDT? (Conference Presentation)
Paper 11070-158
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Photodynamic therapy in primary breast cancer: the first human study (Conference Presentation)
Paper 11070-159
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Discussion
Wednesday 3 July 2019
3:45 PM - 4:00 PM
Location: Salon 3
Coffee Break 3:45 AM - 4:30 AM
Session 25: Low-Cost Systems and Techniques in PDT Light Delivery, Dosimetry, and Treatment Guidance
Wednesday 3 July 2019
2:00 PM - 4:00 PM
Location: Salon 4
Quantum dot light emitting diodes (QLEDs) as low-cost PDT light sources (Conference Presentation) (Invited Paper)
Paper 11070-160
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
ROS explicit dosimetry for photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-161
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Low-cost smartphone-based dosimeter for individualization of PDT treatment planning for protoporphyrin IX based skin cancer treatment (Conference Presentation) (Invited Paper)
Paper 11070-162
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA PDT
Paper 11070-163
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Photodynamic therapy (PDT) based on chlorin e6 in the palliative treatment of head neck malignancies (Conference Presentation)
Paper 11070-164
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Weather forecast and light-tissue model based dose planning for daylight PpIX-photodynamic therapy of skin (Conference Presentation)
Paper 11070-165
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Implantable electronic device and tissue-adhesive nanosheets can introduce photodynamic therapy into inside the body (Conference Presentation)
Paper 11070-166
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Coffee Break 4:00 PM - 4:30 PM
Session 26: Photodynamics and Ionizing Radiation: Friends or Foes?
Wednesday 3 July 2019
2:00 PM - 4:00 PM
Location: Salons 1-2
Using x-ray in photodynamic therapy (Conference Presentation) (Invited Paper)
Paper 11070-167
Time: 2:00 PM - 2:20 PM
Author(s):
Show Abstract
High resolution imaging of tumor pO2 with Cherenkov-excited luminescence scanned imaging (Conference Presentation) (Invited Paper)
Paper 11070-168
Time: 2:20 PM - 2:40 PM
Author(s):
Show Abstract
Radioluminescent nanomaterials to induce deep-tissue PDT: towards a complete description of the therapeutic contributions (Conference Presentation) (Invited Paper)
Paper 11070-169
Time: 2:40 PM - 3:00 PM
Author(s):
Show Abstract
Tumor targeting vitamin B12 derivatives for x-ray activated chemotherapy (Conference Presentation)
Paper 11070-170
Time: 3:00 PM - 3:15 PM
Author(s):
Show Abstract
Targeted XPDT with and without Cherenkov and/or nanoscintillators
Paper 11070-171
Time: 3:15 PM - 3:30 PM
Author(s):
Show Abstract
Using biodegradable chemotherapy-free nanocarriers and low dose x-rays for combined photodynamic therapy of colorectal cancer
Paper 11070-172
Time: 3:30 PM - 3:45 PM
Author(s):
Show Abstract
Liposomal and polymeric nanoformulations for imaging guided photodynamic therapy
Paper 11070-173
Time: 3:45 PM - 4:00 PM
Author(s):
Show Abstract
Coffee Break 4:00 PM - 4:30 PM
Session 27: Applications of Novel PDT Light Sources
Wednesday 3 July 2019
4:30 PM - 6:15 PM
Location: Salons 1-2
An historical perspective of PDT light sources (Invited Paper)
Paper 11070-174
Time: 4:30 PM - 4:50 PM
Author(s):
Show Abstract
Light emitting fabrics for PDT: technology and results of clinical studies (Invited Paper)
Paper 11070-175
Time: 4:50 PM - 5:10 PM
Author(s):
Show Abstract
A low-cost platform for image-guided PDT treatment or oral cancer in resource limited settings (Invited Paper)
Paper 11070-176
Time: 5:10 PM - 5:30 PM
Author(s):
Show Abstract
Light distribution monitoring using an IR navigation system for pleural PDT (Conference Presentation)
Paper 11070-177
Time: 5:30 PM - 5:45 PM
Author(s):
Show Abstract
Flexible organic light-emitting diodes for antimicrobial photodynamic therapy
Paper 11070-178
Time: 5:45 PM - 6:00 PM
Author(s):
Show Abstract
Devices based on light emitting fabrics dedicated to PDT preclinical studies
Paper 11070-179
Time: 6:00 PM - 6:15 PM
Author(s):
Show Abstract
Session 28: From Small Animals to Spheroids: Modelling Mechanisms of PDT Effect on Tissue
Wednesday 3 July 2019
4:30 PM - 6:15 PM
Location: Salon 3
Provocative questions informing preclinical models of PDT research (Invited Paper)
Paper 11070-181
Time: 4:30 PM - 4:50 PM
Author(s):
Show Abstract
Organotypic 3D co-cultures and animal tumor models in comparison to 2D cell cultures: mechanistic differences in treatment responses (Invited Paper)
Paper 11070-182
Time: 4:50 PM - 5:10 PM
Author(s):
Show Abstract
Microenvironmental cues in 3D cancer models to inform targeted PDT combinations (Conference Presentation) (Invited Paper)
Paper 11070-183
Time: 5:10 PM - 5:30 PM
Author(s):
Show Abstract
Surgery-induced immunosuppression of photodynamic therapy efficacy: mechanism and mitigation
Paper 11070-184
Time: 5:30 PM - 5:45 PM
Author(s):
Show Abstract
Evaluation of photomedicine and anti-microRNA combination therapies in 3D cell culture models of pancreatic ductal adenocarcinoma (Conference Presentation)
Paper 11070-185
Time: 5:45 PM - 6:00 PM
Author(s):
Show Abstract
Photodynamic therapy followed by abraxane chemotherapy can significantly suppress pancreatic cancer metastasis (Conference Presentation)
Paper 11070-186
Time: 6:00 PM - 6:15 PM
Author(s):
Show Abstract
Session 29: Photodynamic Diagnosis and Therapy for Gastrointestinal Neoplastic Lesions
Wednesday 3 July 2019
4:30 PM - 6:30 PM
Location: Salon 4
New concepts of photodynamic therapy in unresectable cholangiocarcinoma: 200 cases for 10 years, single center experiences (Invited Paper)
Paper 11070-188
Time: 4:30 PM - 4:50 PM
Author(s):
Show Abstract
Molecular imaging of gastrointestinal tumors (Conference Presentation) (Invited Paper)
Paper 11070-189
Time: 4:50 PM - 5:10 PM
Author(s):
Show Abstract
Endoscopic ultrasound and PDT for pancreatic cancer (Invited Paper)
Paper 11070-190
Time: 5:10 PM - 5:30 PM
Author(s):
Show Abstract
Photodynamic therapy for cholangiocarcinoma
Paper 11070-191
Time: 5:30 PM - 5:45 PM
Author(s):
Show Abstract
Phototherapy-immunostimulant induced tumor-specific immune responses against metastatic cancers
Paper 11070-192
Time: 5:45 PM - 6:00 PM
Author(s):
Show Abstract
The impact of photodynamic therapy therapy with polarity-tunable bacteriochlorins on the antitumor immunity: local effects and systemic consequences (Conference Presentation)
Paper 11070-334
Time: 6:00 PM - 6:15 PM
Author(s):
Show Abstract
Efficacy of photodynamic therapy with a new photosensitizer (talaporfin sodium) as a salvage treatment for local failure of esophageal cancer (Conference Presentation)
Paper 11070-13
Time: 6:15 PM - 6:30 PM
Author(s):
Show Abstract
Thursday 4 July Show All Abstracts
Roadmap to Impact: Challenges in Translating PDT Technologies and a Way Forward
Thursday 4 July 2019
8:30 AM - 12:30 PM
Location: Salon 3

Taking the stock of PDT today, this panel will explore ways that IPA can better support its membership and the global PDT community. The role of social media platforms will be presented to enable greater membership engagement and interaction. The panel will present the challenges and opportunities for PDT and how these may evolve over time. Strategies to ensure greater collaboration as well as a coordinated approach to research and clinical development that can lead to sustainable adoption of PDT as a standard of care in global healthcare systems will also be discussed.
Coffee Break 10:00 AM - 10:30 AM
Conference Committee
Back to Top
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray